(CIRB) A Phase III Study of Postoperative Radiation Therapy (IMRT) +/-Cetuximab for Locally-Advanced Resected Head and Neck Cancer

RTOG-0920
NCT00956007
Cancer - Larynx, Cancer - Lip, Oral Cavity and Pharynx
Chaitali Nangia
Open
Treatment
Cetuximab, Erbitux
III
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.